Stefanie Altmann, DO
Dermatology · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 15
- 3 carriers
- Office
- 1
- Since medical school
- 8 years
- Graduated 2018
Offices
1 location · Berman Skin Institute Medical Group Inc · 26 clinicians in this group
Plans that list them
15 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Altmann’s office at (925) 932-3800 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
15 of 15 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
State licence records
1 licence
- Florida OS18824Osteopathic Physician · since 2022 · expires 2028-03-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
2 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- Nova Southeastern University · Doctor of Osteopathic Medicine2014–2018Medical school
Residency and fellowship
- HCA/Mercer Univ School of Med/Orange Park Medical, DERMATOLOGYOrange Park, US · 2019–2022
- Good Samaritan Regional Medical Center, TRANSITIONAL YEARCorvallis, OR · 2018–2019
What else the board holds
Also licensed in
States the clinician told their board they are also licensed in. Only the states we check are verified.
Oregon
Original Medicare doctor bills
$685,303
Medicare paid this office $685,303 for 749 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 240 | $160,517 | $474 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 135 | $76,450 | $335 |
| Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | 71 | $45,941 | $499 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 152 | $39,169 | $201 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 108 | $34,393 | $242 |
See all 31 services
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 240 | $160,517 | $474 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 135 | $76,450 | $335 |
| Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | 71 | $45,941 | $499 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 152 | $39,169 | $201 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 108 | $34,393 | $242 |
| Return visit (30+ min) | 277 | $33,567 | $89 |
| Biopsy of related skin growth, first growth | 260 | $21,316 | $65 |
| Short return visit (20+ min) | 243 | $18,162 | $62 |
| Destruction of precancer skin growth, 15 or more growths | 119 | $17,244 | $124 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 48 | $16,079 | $287 |
| Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | 19 | $15,433 | $812 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | 16 | $12,216 | $764 |
| Repair of wound by transferring skin, 30.1-60.0 sq cm | 13 | $11,756 | $904 |
| Biopsy of related skin growth, each additional growth | 132 | $11,063 | $41 |
| Destruction of precancer skin growth, 1 growth | 244 | $10,660 | $36 |
| Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | 17 | $7,797 | $325 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 20 | $7,756 | None |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 52 | $7,407 | $116 |
| Destruction of skin growth, 1-14 growths | 75 | $6,908 | $81 |
| New patient visit (45+ min) | 57 | $5,686 | $100 |
| Destruction of precancer skin growth, 2-14 growths | 194 | $5,361 | $5 |
| Application of light with debridement to destroy precancer skin growth | 19 | $4,258 | $213 |
| New patient visit (30+ min) | 46 | $3,041 | $66 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 21 | $2,743 | $125 |
| Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | 12 | $2,526 | $210 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 18 | $2,128 | $106 |
| Short return visit | 43 | $1,819 | $38 |
| Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm | 11 | $1,621 | $135 |
| Biopsy of ear | 17 | $1,123 | $51 |
| Injection into skin growth, 1-7 growths | 12 | $385 | $30 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 12 | $12 | None |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 67 | More than 89% of doctors who do this |
| Removal of skin cancer | 298 | More than 44% of doctors who do this |
| Removal of skin lesions | 283 | More than 82% of doctors who do this |
| Removal of tissue | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
| Skin biopsy | 136 | More than 80% of doctors who do this |
Procedures year by year
| Procedure | 2022 | 2023 | 2024 |
|---|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 777 | 1,863 | 1,066 |
| Destruction of precancer skin growth, 1 growth | 183 | 553 | 296 |
| Biopsy of related skin growth, first growth | 145 | 477 | 328 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 32 | 412 | 339 |
| Biopsy of related skin growth, each additional growth | 75 | 338 | 272 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 29 | 345 | 228 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
749 Original Medicare patients in 2024. Average age 75 · Under 65 2% · 85 and older 12% · Women 50% · Also on Medicaid 3% · Health risk score 0.98. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 70% · Coronary heart disease 30% · Diabetes 18% · Cancer 17% · Atrial fibrillation 17% · Chronic kidney disease 15% · Depression 15% · COPD 12% · Heart failure 9% · Stroke 7% · Dementia 4%.
The office billed $2,065,145, Medicare allowed $895,319 and paid $685,303; for 4,742 services of 95 kinds; $10,709 of it was for drugs given in the office and $674,594 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 749 | 4,742 | 75 | 0.98 | $2,065,145 | $685,303 |
| 2023 | 900 | 7,319 | 75 | 0.95 | $2,774,367 | $924,883 |
| 2022 | 378 | 2,030 | 75 | 0.81 | $409,691 | $144,960 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 36 services
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 285 | $204,471 | $496 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 181 | $119,016 | $345 |
| Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | 92 | $53,616 | $506 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 183 | $48,290 | $210 |
| Return visit (30+ min) | 346 | $46,536 | $92 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 83 | $44,157 | None |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 119 | $35,449 | $244 |
| Destruction of precancer skin growth, 15 or more growths | 203 | $34,535 | $135 |
| Biopsy of related skin growth, first growth | 374 | $32,243 | $68 |
| Short return visit (20+ min) | 393 | $30,296 | $63 |
| Application of light with debridement to destroy precancer skin growth | 78 | $24,204 | $218 |
| Destruction of precancer skin growth, 1 growth | 430 | $21,189 | $38 |
| Kerecis omega3, per square centimeter | 16 | $20,356 | $118 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 66 | $20,285 | $282 |
| Repair of wound by transferring skin, 30.1-60.0 sq cm | 20 | $20,031 | $954 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | 17 | $14,540 | $855 |
| Biopsy of related skin growth, each additional growth | 178 | $14,207 | $42 |
| Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | 29 | $12,952 | $316 |
| Destruction of skin growth, 1-14 growths | 135 | $12,638 | $82 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 18 | $12,476 | $657 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | 16 | $12,292 | $768 |
| Destruction of precancer skin growth, 2-14 growths | 336 | $9,793 | $5 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 62 | $8,282 | $118 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 48 | $7,057 | $118 |
| New patient visit (45+ min) | 52 | $4,965 | $95 |
| New patient visit (30+ min) | 55 | $3,753 | $68 |
| Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | 16 | $3,435 | $215 |
| Short return visit | 71 | $3,382 | $40 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 21 | $2,399 | $104 |
| Complicated repair of wound of scalp, arms, or legs, each additional 5.0 cm or less | 21 | $2,342 | $112 |
| Biopsy of ear | 39 | $2,130 | $46 |
| Removal of tissue from wound, 20.0 sq cm or less | 12 | $1,762 | $84 |
| Complicated repair of wound of trunk, each additional 5.0 cm or less | 11 | $1,227 | $102 |
| Injection into skin growth, 1-7 growths | 18 | $1,044 | $34 |
| Administration of chemotherapy into growth, 1-7 | 12 | $428 | $33 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 13 | $29 | None |
2022: 20 services
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 28 | $16,926 | $529 |
| Short return visit (20+ min) | 188 | $15,067 | $76 |
| Return visit (30+ min) | 109 | $12,498 | $106 |
| Biopsy of related skin growth, first growth | 142 | $12,018 | $83 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 14 | $10,092 | $348 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 23 | $8,946 | None |
| Destruction of precancer skin growth, 15 or more growths | 55 | $7,873 | $143 |
| Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | 22 | $7,740 | $352 |
| Destruction of precancer skin growth, 1 growth | 174 | $7,673 | $42 |
| Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 19 | $5,332 | $254 |
| Destruction of precancer skin growth, 2-14 growths | 141 | $4,278 | $6 |
| Complicated repair of wound of trunk, 2.6-7.5 cm | 13 | $4,146 | $319 |
| Application of light by qualified health care professional to destroy precancer skin growth | 20 | $4,074 | $194 |
| Destruction of skin growth, 1-14 growths | 37 | $3,631 | $93 |
| Biopsy of related skin growth, each additional growth | 46 | $3,277 | $44 |
| Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | 18 | $2,177 | $121 |
| New patient visit (30+ min) | 18 | $1,711 | $95 |
| Short return visit | 20 | $1,071 | $49 |
| Injection into skin growth, 1-7 growths | 12 | $485 | $37 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $28 | None |
Drugs they prescribed that Part D paid
$22,549
Pharmacies billed $22,549 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (19 of 1,126) in 2024. A higher opioid share than 9 in 10 peers; the typical dermatology clinician is at 0%.
1,120 generic and fewer than 11 brand-name prescriptions · $22,549 in drug cost · 245 antibiotic prescriptions to 192 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gentamicin Sulfate | 143 | $4,432 | $31 |
| Mupirocin | 264 | $1,980 | $7 |
| Clobetasol Propionate | 49 | $1,857 | $38 |
| Fluorouracil | 37 | $1,811 | $49 |
| Ketoconazole | 81 | $1,310 | $16 |
See all 14 drugs
| Gentamicin Sulfate | 143 | $4,432 | $31 |
| Mupirocin | 264 | $1,980 | $7 |
| Clobetasol Propionate | 49 | $1,857 | $38 |
| Fluorouracil | 37 | $1,811 | $49 |
| Ketoconazole | 81 | $1,310 | $16 |
| Doxycycline Hyclate | 113 | $1,180 | $10 |
| Triamcinolone Acetonide | 150 | $1,091 | $7 |
| Doxycycline Monohydrate | 55 | $742 | $13 |
| Fluocinonide | 15 | $496 | $33 |
| Ciclopirox | 12 | $494 | $41 |
| Clindamycin Phosphate | 11 | $333 | $30 |
| Cephalexin | 51 | $327 | $6 |
| Hydrocortisone | 43 | $234 | $5 |
| Hydrocodone-Acetaminophen | 14 | $62 | $4 |
Year by year
| 2024 | 1,126 | 576 | 2% (19) | None | $22,549 |
| 2023 | 1,086 | 505 | 1% (14) | None | $31,318 |
| 2022 | 285 | 175 | 0% (0) | None | $8,559 |
| 2020 | 31 | None | 0% (0) | None | $2,643 |
| 2019 | 64 | None | None | None | $2,983 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Gentamicin Sulfate | 210 | $9,454 | $45 |
| Ketoconazole | 107 | $3,049 | $28 |
| Fluorouracil | 34 | $2,562 | $75 |
| Doxycycline Hyclate | 111 | $2,039 | $18 |
| Triamcinolone Acetonide | 122 | $1,249 | $10 |
| Clobetasol Propionate | 30 | $1,174 | $39 |
| Mupirocin | 128 | $1,167 | $9 |
| Fluocinonide | 23 | $1,144 | $50 |
| Metronidazole | 11 | $1,111 | $101 |
| Cephalexin | 85 | $757 | $9 |
| Ciclopirox | 16 | $583 | $36 |
| Hydroxychloroquine Sulfate | 11 | $485 | $44 |
| Doxycycline Monohydrate | 19 | $469 | $25 |
| Hydrocortisone | 59 | $391 | $7 |
| Valacyclovir | 20 | $390 | $19 |
2022: 8 drugs
| Fluorouracil | 23 | $2,089 | $91 |
| Ketoconazole | 47 | $1,590 | $34 |
| Gentamicin Sulfate | 19 | $773 | $41 |
| Doxycycline Hyclate | 23 | $663 | $29 |
| Triamcinolone Acetonide | 37 | $374 | $10 |
| Mupirocin | 37 | $309 | $8 |
| Hydrocortisone | 20 | $111 | $6 |
| Cephalexin | 16 | $109 | $7 |
2019: 3 drugs
| Atorvastatin | 12 | $210 | $17 |
| Isosorbide Mononitrate Er | 12 | $170 | $14 |
| Furosemide | 12 | $63 | $5 |
Money from drug and device companies
$957 in 2025
| 2025 | 16 | 47 | None | $957 |
| 2024 | 15 | 32 | None | $763 |
| 2023 | 6 | 9 | None | $385 |
| 2022 | 13 | 29 | None | $1,854 |
| 2021 | 10 | 29 | None | $1,118 |
| 2020 | 9 | 16 | None | $491 |
| 2019 | 6 | 11 | None | $563 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Ucb | Bimzelx | $241 | 7 payments
|
| Abbvie | Rinvoq | $150 | 10 payments
|
| Novartis Pharmaceuticals | Cosentyx | $116 | 5 payments
|
| Lilly USA | Taltz | $96 | 5 payments
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $53 | 2 payments
|
| Sun Pharmaceutical Industries | Leqselvi | $49 | 2 payments
|
See all 47 published payments
| Abbvie | Meals · 2025-12-08 | Rinvoq | $22 |
| Abbvie | Meals · 2025-10-29 | None | $18 |
| Abbvie | Meals · 2025-09-24 | Skyrizi | $23 |
| Abbvie | Meals · 2025-09-04 | Rinvoq | $3 |
| Abbvie | Meals · 2025-09-04 | Rinvoq | $8 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-08-21 | Spevigo | $21 |
| Lilly USA | Meals · 2025-08-20 | Taltz | $21 |
| Smith+Nephew | Meals · 2025-07-31 | Collagenase Santyl | $27 |
| Novartis Pharmaceuticals | Meals · 2025-07-30 | None | $30 |
| Sun Pharmaceutical Industries | Meals · 2025-07-29 | Leqselvi | $25 |
| Ucb | Meals · 2025-07-28 | Bimzelx | $31 |
| Surgenex | Meals · 2025-07-08 | Surgraft | $20 |
| Ucb | Meals · 2025-06-30 | Bimzelx | $42 |
| Novartis Pharmaceuticals | Meals · 2025-06-17 | Cosentyx | $23 |
| Genzyme | Meals · 2025-06-09 | Dupixent | $41 |
| Abbvie | Meals · 2025-05-29 | Rinvoq | $16 |
| Abbvie | Meals · 2025-05-22 | Rinvoq | $25 |
| Lilly USA | Meals · 2025-05-21 | Taltz | $18 |
| Ucb | Meals · 2025-05-19 | Bimzelx | $24 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-05-14 | Spevigo | $32 |
| Verrica Pharmaceuticals | Meals · 2025-05-12 | Ycanth | $21 |
| Novartis Pharmaceuticals | Meals · 2025-04-29 | Cosentyx | $20 |
| Ucb | Meals · 2025-04-17 | Bimzelx | $22 |
| Lilly USA | Meals · 2025-04-08 | Taltz | $16 |
| Kerecis | Meals · 2025-04-08 | Kerecis Surgiclose | $6 |
| Regeneron Healthcare Solutions | Meals · 2025-03-25 | Dupixent | $18 |
| Ucb | Meals · 2025-03-24 | Bimzelx | $45 |
| Organon | Meals · 2025-03-24 | Vtama | $3 |
| Kerecis | Meals · 2025-03-19 | Kerecis Surgiclose | $21 |
| Amgen | Meals · 2025-03-13 | Otezla | $16 |
| Kerecis | Meals · 2025-03-12 | Kerecis Surgiclose | $5 |
| Abbvie | Meals · 2025-02-28 | Skyrizi | $8 |
| Novartis Pharmaceuticals | Meals · 2025-02-26 | None | $25 |
| Lilly USA | Meals · 2025-02-25 | Taltz | $20 |
| Sun Pharmaceutical Industries | Meals · 2025-02-24 | Ilumya | $24 |
| Ucb | Meals · 2025-02-20 | Bimzelx | $39 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-12 | Sotyktu | $18 |
| ConvaTec | Meals · 2025-02-11 | Innovaburn | $16 |
| Organon | Meals · 2025-02-03 | Vtama | $5 |
| Abbvie | Meals · 2025-01-30 | Skyrizi | $10 |
| Abbvie | Meals · 2025-01-30 | Skyrizi | $17 |
| Novartis Pharmaceuticals | Meals · 2025-01-29 | Cosentyx | $17 |
| Ucb | Meals · 2025-01-28 | Bimzelx | $39 |
| Lilly USA | Meals · 2025-01-22 | Taltz | $22 |
| Organon | Meals · 2025-01-21 | Vtama | $4 |
| Surgenex | Meals · 2025-01-13 | Surgraft | $26 |
| Organon | Meals · 2025-01-06 | Vtama | $4 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $763
| Lilly USA | Taltz | $189 | 6 payments
|
| Genzyme | Dupixent | $113 | 4 payments
|
| Sanofi-Aventis U.S. | Dupixent | $99 | 1 payment
|
| Abbvie | Skyrizi | $62 | 4 payments
|
| Sun Pharmaceutical Industries | Ilumya | $56 | 2 payments
|
| Kerecis | Kerecis Omega3 Surgiclose | $42 | 2 payments
|
| Ucb | Bimzelx | $36 | 1 payment
|
| Janssen Biotech | Tremfya | $26 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Spevigo | $25 | 1 payment
|
| Blueprint Medicines | Ayvakit | $24 | 1 payment
|
| Almirall | Seysara | $22 | 1 payment
|
| ConvaTec | Innovamatrix Ac | $19 | 1 payment
|
| Amgen | Otezla | $19 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $18 | 1 payment
|
| Galderma Laboratories L.P. | Aklief | $15 | 1 payment
|
2023: $385
| Janssen Biotech | Tremfya | $147 | 1 payment
|
| Arcutis Biotherapeutics | None | $112 | 2 payments
|
| Kerecis | Kerecis Omega3 Surgiclose | $45 | 2 payments
|
| AbbVie | Skyrizi | $37 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $24 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $21 | 1 payment
|
2022: $1,854
| Kerecis | Kerecis Omega3 Surgiclose | $347 | 1 payment
|
| Lilly USA | Taltz | $342 | 4 payments
|
| Abbvie | Skyrizi | $309 | 7 payments
|
| Incyte | Opzelura | $153 | 4 payments
|
| Galderma Laboratories L.P. | Twyneo | $134 | 1 payment
|
| Genentech USA | Erivedge | $128 | 1 payment
|
| Ucb | Cimzia | $124 | 1 payment
|
| Janssen Biotech | Tremfya | $90 | 1 payment
|
| Sun Pharmaceutical Industries | Winlevi | $82 | 1 payment
|
| Genzyme | Dupixent | $71 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $33 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $25 | 1 payment
|
| Almirall | Seysara | $16 | 1 payment
|
2021: $1,118
| Genzyme | Dupixent | $250 | 3 payments
|
| Janssen Scientific Affairs | Tremfya | $210 | 2 payments
|
| AbbVie | Skyrizi | $162 | 10 payments
|
| Incyte | Opzelura | $147 | 3 payments
|
| Janssen Biotech | Tremfya | $108 | 2 payments
|
| Sanofi-Aventis U.S. | Dupixent | $80 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $59 | 3 payments
|
| Lilly USA | Taltz | $50 | 2 payments
|
| Ortho Dermatologics a division of Bausch Health US | Jublia | $32 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $20 | 1 payment
|
2020: $491
| Janssen Scientific Affairs | Tremfya | $114 | 1 payment
|
| AbbVie | Humira | $92 | 5 payments
|
| Ortho Dermatologics a division of Bausch Health US | Bryhali | $86 | 2 payments
|
| Helsinn Therapeutics (U.S.) | Valchlor | $67 | 1 payment
|
| Lilly USA | Taltz | $44 | 2 payments
|
| Almirall | Seysara | $33 | 2 payments
|
| Janssen Biotech | Tremfya | $21 | 1 payment
|
| Dermira | Qbrexza | $19 | 1 payment
|
| VYNE Pharmaceuticals | Amzeeq | $15 | 1 payment
|
2019: $563
| Regeneron Healthcare Solutions | Dupixent | $133 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $129 | 2 payments
|
| Ucb | Cimzia | $115 | 1 payment
|
| Sun Pharmaceutical Industries | Ilumya | $100 | 1 payment
|
| Lilly USA | Taltz | $67 | 4 payments
|
| Biofrontera | Ameluz | $19 | 1 payment
|
Professional record
- NPI
- 1912494188
- Licence
- FL OS18824, FL UO6375, OR PG188434Florida OS18824: Active
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X); Federal specialty code 207N00000X (207N00000X); Federal specialty code 207ND0101X (207ND0101X)
- Mailing address
- 4000 Hollywood Blvd Ste 215-A, Hollywood, FL, 33021
- NPI first listed
- 2018-04-13
- NPI last updated
- 2026-05-07
- NPI record certified
- 2026-05-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 82883 Overseas Highway, Islamorada, FL, 33036 · 1010 Kennedy Dr Ste 304, Key West, FL, 33040 · 5575 W Las Positas Blvd Ste 230, Pleasanton, CA, 94588